Enfuvirtide (T-20): A Novel Human Immunodeficiency Virus Type 1 Fusion Inhibitor

Cervia, Joseph S.; Smith, Miriam A.
October 2003
Clinical Infectious Diseases;10/15/2003, Vol. 37 Issue 8, p1102
Academic Journal
Describes the development of highly active antiretroviral therapy in reducing the progression of AIDS in HIV-infected patients in the U.S. Improvement of the life expectancy of patients; Conformational changes in the HIV envelope glycoprotein 41; Sensitivity of viral envelope to synthetic peptide enfuvirtide.


Related Articles

  • Cancer Burden Shifts for People With HIV/AIDS.  // JNCI: Journal of the National Cancer Institute;May2011, Vol. 103 Issue 9, pNP 

    The article discusses the findings of research about the incidence and types of cancer among people with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) in the U.S. According to researchers from the National Cancer Institute (NCI) and the Centers for Disease Control...

  • Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda. Kipp, Walter; Konde-Lule, Joseph; Rubaale, Tom; Okech-Ojony, Joa; Alibhai, Arif; Saunders, Duncan L. // BMC International Health & Human Rights;2011 Supplement 2, Vol. 11 Issue Suppl 2, p1 

    Background: Improved availability of antiretroviral therapy in sub-Saharan Africa is intended to benefit all eligible HIV-infected patients; however in reality antiretroviral services are mainly offered in urban hospitals. Poor rural patients have difficulty accessing the drugs, making the...

  • Effect of Highly Active Antiretroviral Therapy on the Incidence and Clinical Manifestations of Visceral Leishmaniasis in Human Immunodeficiency Virus--Infected Patients. Cotarelo, M.J. Fernández; Martinez, J. Abellán; Vales, J.M. Guerra; Sánchez, P. Martínez; de la Bárcena, M. Rodrigo Gómez; Fernández, E. Salto // Clinical Infectious Diseases;10/1/2003, Vol. 37 Issue 7, p973 

    Examines the effect of highly active antiretroviral therapy on the incidence and clinical manifestations in HIV-infected patients. Characterization of the advanced stage of HIV infection; Risk factor for developing visceral leishmaniasis; Consideration of the diagnostic criterion for AIDS.

  • Optimizing Predictive Mining Techniques in HIV-Related Opportunistic Infections: Case for Botswana. Buthu'gwashe; Zhiyong Li; Kirui, Clement // International Journal of Computer Applications;Aug2013, Vol. 76 Issue 1-16, p1 

    Botswana was one of the first countries to establish a national Antiretroviral therapy (ART) programme in Africa. "Masa," a native word depicting "a new dawn," is the programme name. The AIDS epidemic has led to the emergence of several disease entities which in the pre-AIDS era seemed...

  • LATE REPORTING AMONG NEWLY REGISTERED PATIENTS FOR ANTI RETROVIRAL THERAPY IN A CENTRAL DISTRICT UJJAIN, INDIA. Khandelwal, Vidit; Sabde, Yogesh D.; Pradhan, Riddhi; Sathsh, Mehta Chandra // National Journal of Community Medicine;Oct-Dec2013, Vol. 4 Issue 4, p624 

    Introduction: Current trends in HIV/AIDS epidemic demand quality and sustainable programs to provide universal access to antiretroviral therapy (ART). The inherent disparities in population subgroups result in changing profiles of ART beneficiaries which are needed to account for with reference...

  • Free antiretroviral treatment effective in Malawi.  // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p39 

    The article reports on the results of a study on the efficiency of antiretroviral therapy in Malawi. It revealed that mortality rates of patients with HIV and AIDS have been reduced following the introduction of free antiretroviral therapy. According to researchers, the mortality rate was 9.8...

  • Role of Uncontrolled HIV RNA Level and Immunodeficiency in the Occurrence of Malignancy in HIV-Infected Patients during the Combination Antiretroviral Therapy Era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Bruyand, Mathias; Thie'baut, Rodolphe; Lawson-Ayayi, Sylvie; Joly, Pierre; Sasco, Annie Jeanne; Mercie', Patrick; Pellegrin, Jean Luc; Neau, Didier; Dabis, François; Morlat, Philippe; Chêne, Geneviève; Bonnet, Fabrice // Clinical Infectious Diseases;10/1/2009, Vol. 49 Issue 7, p1109 

    Background. Human immunodeficiency virus (HIV)-infected patients are at higher risk of malignancies. In addition to traditional determinants, a specific deleterious effect of HIV and immunodeficiency is speculated. We aimed at studying the association between immunological and virological...

  • The Pattern of the Initial Anti-retroviral Drug Regimens in HIV Patients at a Tertiary Care Hospital. PRAKASH RAJU, G. J. K.; CHOWTA, MUKTA N.; RATHER, ZAHOOR AHMAD; MUBEEN, FAHEEM // Journal of Clinical & Diagnostic Research;Sep2012, Vol. 6 Issue 7, p1178 

    Background and objective: The choice of the anti-retroviral drug therapy has been evolving over the last decade. The objective of this study was to evaluate the current prescribing pattern of the anti-retroviral drugs in treatment-naïve patients before initiating the anti-retroviral therapy....

  • When to Start Antiretroviral Therapy in Resource-Limited Settings. Rochelle P. Walensky; Lindsey L. Wolf; Robin Wood; Mariam O. Fofana; Kenneth A. Freedberg; Neil A. Martinson; A. David Paltiel; Xavier Anglaret; Milton C. Weinstein; Elena Losina // Annals of Internal Medicine;8/4/2009, Vol. 151 Issue 3, p157 

    Background: The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years. Objective: To inform HIV treatment decisions about the optimal CD4 threshold at which to initiate ART in South Africa while awaiting...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics